Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Impact of Systematic Pharmacokinetic (PK) Profiles in a Cohort of 29 Patients Treated with Conventional and Extended-Half Life (EHL) Products

Teresa Ceglie, Berardino Pollio, Irene Ricca, Maria Messina, Claudia Linari, Mauro Pagliarino

Blood (2019) 134 (Supplement_1): 1123.

https://doi.org/10.1182/blood-2019-132199

Published: 2019

Journal Articles

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

Janice Kim, PharmD, MSc, Bindu Kanapuru, MD, Jessica K Roydhouse, PhD MPH, Ann T. Farrell, MD, Najat Bouchkouj, MD, Hussein Ezzeldin, PhD, Paul Kluetz, MD

Blood (2019) 134 (Supplement_1): 3450.

https://doi.org/10.1182/blood-2019-125798

Published: 2019

Journal Articles

An Observational Study of the Prescribing Practices and Patient Reported Outcomes Measures in Older People with Myelodysplastic Syndrome

Angela Molga, MBBS, Michelle Wall, Dip HE (Nursing), BA (Hons), MSc, PG Cert, Rakchha Chhetri, MBBS, Amilia Wee, BSc (Hons), Deepak Singhal, MBBS, MDFRACP, FRCPA, Pratyush Giri, MBBS,FRACP,FRCPA, Timothy To, BSc, BMBS, FRACP, FAChPM, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2019) 134 (Supplement_1): 5426.

https://doi.org/10.1182/blood-2019-132164

Published: 2019

Journal Articles

An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service

Helen Cashman, MBBS, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA, John Moore, MDFRACP,FRCPA, Sam Milliken, MBBS, FRACP, FRCPA, Orly Lavee, MD, Barbara Withers, Eleni Mayson, FRACP, FRCPA, MBBS, MPhil, David Kliman, MBBS, Janet Kesby, Jenny Bell, Sue Vachalec

Blood (2019) 134 (Supplement_1): 4709.

https://doi.org/10.1182/blood-2019-127796

Published: 2019

Journal Articles

Pediatric Patient-Reported Symptom Tracking in Oncology (Pedi-PReSTO): A Feasibility Study

Allison Barz Leahy, MD, Gabrielle Helton, Dylan Scholes, Andrew Jurgielewicz, Bryce B Reeve, PhD, Schwartz Lisa, PhD, Richard Aplenc, MD PhD, Ethan Basch, MD MSc

Blood (2018) 132 (Supplement 1): 2290.

https://doi.org/10.1182/blood-2018-99-119902

Published: 2018

Journal Articles

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Nadirah El-Amin, MPH, DO, Paul Nietert, PhD, Julie Kanter, MD

Blood (2018) 132 (Supplement 1): 2371.

https://doi.org/10.1182/blood-2018-99-117206

Published: 2018

Journal Articles

Physician Prescribing Practices in Sickle Cell Disease

Foluso Joy Ogunsile, MD, Zhuo Tony Su, BSc, Sophie Lanzkron, MD, Jodi Segal

Blood (2017) 130 (Supplement 1): 3540.

https://doi.org/10.1182/blood.V130.Suppl_1.3540.3540

Published: 2017

Journal Articles

Opioid Prescription Practices at Discharge and 30-Day Returns in Children with Sickle Cell Disease and Pain

Leslie M Okorji, BS, Devin S Muntz, BS, Robert I Liem, MD MS

Blood (2015) 126 (23): 3417.

https://doi.org/10.1182/blood.V126.23.3417.3417

Published: 2015

Journal Articles

Real-World Ponatinib Prescribing Patterns and Outcomes in US Patients

Michael J. Mauro, MD, Lisa J. McGarry, MPH, Mo Yang, PhD, Stephanie Lustgarten, PhD, Hui Huang, MBA, PhD

Blood (2015) 126 (23): 1591.

https://doi.org/10.1182/blood.V126.23.1591.1591

Published: 2015

Journal Articles

Trends in First Line Prescribing Preferences Among US-Based Hematology-Oncology Physicians for Patients with Multiple Myeloma Who Are Not Candidates for or Elect Not to Undergo Stem Cell Transplant

Joel H Schwartz, MD, Joanne Willey, RN, Arden Buettner, Mitch Scharf, Maria Lankford, Mark R. Green, MD, Katarzyna Puto, PharmD, MBA

Blood (2014) 124 (21): 5776.

https://doi.org/10.1182/blood.V124.21.5776.5776

Published: 2014

Journal Articles

First-Line Prescribing Preferences of U.S. Hematology-Oncology Physicians for Patients with CLL: Impact of Novel Agents

Mark R. Green, MD, Michael E. Williams, MD, Joanne Willey, RN, Arden Buettner, Douglas Neely, Maria Lankford

Blood (2014) 124 (21): 4676.

https://doi.org/10.1182/blood.V124.21.4676.4676

Published: 2014

Journal Articles

Real-World Prescribing Patterns with Ponatinib Among New and Ongoing US Patients

Lisa J McGarry, MPH, Greg Wolfe, PharmD, Ann Steagall, BSN, RN, OCN, Hui Huang, PhD MBA

Blood (2014) 124 (21): 5521.

https://doi.org/10.1182/blood.V124.21.5521.5521

Published: 2014

Journal Articles

Appropriateness Of Prescribing Of Direct Oral Anticoagulants: A Prospective Cohort Study At CHU UCL Mont-Godinne-Dinant

Anne-Sophie Larock, PharmD, François Mullier, Professor, Jonathan Douxfils, PhD, Jean-Michel Dogné, Christian Chatelain, Anne Spinewine

Blood (2013) 122 (21): 4809.

https://doi.org/10.1182/blood.V122.21.4809.4809

Published: 2013

Journal Articles

First-Line Prescribing Preferences of American Hematology-Oncology Physicians for Patients with CLL: Impact of Age, Co-Morbidities, and Tempo of Disease

Mark R. Green, MD, Michael E. Williams, MD, Joanne Willey, RN, Mitchell Scharf, Douglas Neely, Michael G. Heckman, MS, James M. Foran, MD, FRCPC

Blood (2012) 120 (21): 4608.

https://doi.org/10.1182/blood.V120.21.4608.4608

Published: 2012

Journal Articles

Treatment of Higher-Risk Myelodysplastic Syndrome (MDS) by American Hematology-Oncology Providers (AHOP's): Changes in 1st-Line Treatment Preferences Over Time in Relation to Cytogenetics & Survival Data From Randomized Studies (2006–2010),

James M. Foran, MD, FRCPC, Michael G. Heckman, MS, Michael E. Williams, MD, Joanne Willey, RN, Mark R. Green, MD

Blood (2011) 118 (21): 3816.

https://doi.org/10.1182/blood.V118.21.3816.3816

Published: 2011

Journal Articles

Real-World Analysis of Venous Thromboembolism Rates and Thromboprophylaxis Prescribing In US Patients with Cancer.

Alpesh N Amin, Jay Lin, PhD, MBA, Stephen Thompson, MS, Daniel Wiederkehr

Blood (2010) 116 (21): 3802.

https://doi.org/10.1182/blood.V116.21.3802.3802

Published: 2010

Journal Articles

A Retrospective Review of Erythrocyte Stimulating Agents (ESA) Usage in Pharmacy Claims Data.

Scott A Lust, RPh, Milayna Subar, MD, Richard Faris, PhD, DPh, Wenlong Lin, MS, S. Jay Weaver, PharmD, MPH, Lorraine Tully, RHIT

Blood (2009) 114 (22): 900.

https://doi.org/10.1182/blood.V114.22.900.900

Published: 2009

Journal Articles

Choosing First-Line Therapy for Follicular Lymphoma (FL): A Decision Analysis

Rebecca L. Olin, MD, Peter A. Kanetsky, PhD, MPH, Thomas Ten Have, PhD, MPH, Sunita Dwivedy Nasta, MD, Stephen J. Schuster, MD, Charalambos Andreadis, MD, MSCE

Blood (2008) 112 (11): 670.

https://doi.org/10.1182/blood.V112.11.670.670

Published: 2008

Journal Articles

A Budget Impact Model Comparing Resource Utilization of Four Approved Therapies for Multiple Myeloma (MM) in the US.

D.S. Pete Fullerton, Holly Trautman, Hui Huang, Jelena Veljkovic, Dixie-Lee Esseltine, Jing Marantz

Blood (2007) 110 (11): 3324.

https://doi.org/10.1182/blood.V110.11.3324.3324

Published: 2007

Journal Articles

Current Prevalence of Specific Clinical Outcomes in Adult Patients with Hb SS or Hb Sβ 0 Thalassemia.

Laura M. De Castro, MD, Felicia C. Lennon-Graham, MBA, Allison G. Ashley-Koch, PhD, Jude C. Jonassaint, RN, James J. Eckman, MD, Eugene P. Orringer, MD, Marilyn J. Telen, MD

Blood (2006) 108 (11): 1201.

https://doi.org/10.1182/blood.V108.11.1201.1201

Published: 2006

NARROW

Impact of Systematic Pharmacokinetic (PK) Profiles in a Cohort of 29 Patients Treated with Conventional and Extended-Half Life (EHL) Products

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

An Observational Study of the Prescribing Practices and Patient Reported Outcomes Measures in Older People with Myelodysplastic Syndrome

An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service

Pediatric Patient-Reported Symptom Tracking in Oncology (Pedi-PReSTO): A Feasibility Study

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Physician Prescribing Practices in Sickle Cell Disease

Opioid Prescription Practices at Discharge and 30-Day Returns in Children with Sickle Cell Disease and Pain

Real-World Ponatinib Prescribing Patterns and Outcomes in US Patients

Trends in First Line Prescribing Preferences Among US-Based Hematology-Oncology Physicians for Patients with Multiple Myeloma Who Are Not Candidates for or Elect Not to Undergo Stem Cell Transplant

First-Line Prescribing Preferences of U.S. Hematology-Oncology Physicians for Patients with CLL: Impact of Novel Agents

Real-World Prescribing Patterns with Ponatinib Among New and Ongoing US Patients

Appropriateness Of Prescribing Of Direct Oral Anticoagulants: A Prospective Cohort Study At CHU UCL Mont-Godinne-Dinant

First-Line Prescribing Preferences of American Hematology-Oncology Physicians for Patients with CLL: Impact of Age, Co-Morbidities, and Tempo of Disease

Treatment of Higher-Risk Myelodysplastic Syndrome (MDS) by American Hematology-Oncology Providers (AHOP's): Changes in 1st-Line Treatment Preferences Over Time in Relation to Cytogenetics & Survival Data From Randomized Studies (2006–2010),

Real-World Analysis of Venous Thromboembolism Rates and Thromboprophylaxis Prescribing In US Patients with Cancer.

A Retrospective Review of Erythrocyte Stimulating Agents (ESA) Usage in Pharmacy Claims Data.

Choosing First-Line Therapy for Follicular Lymphoma (FL): A Decision Analysis

A Budget Impact Model Comparing Resource Utilization of Four Approved Therapies for Multiple Myeloma (MM) in the US.

Current Prevalence of Specific Clinical Outcomes in Adult Patients with Hb SS or Hb Sβ 0 Thalassemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only